KDM4C and ovarian carcinoma: In recent research on ovarian cancer stem cells, luteolin was found to bind directly with KDM4C that results in decrease stemness of these cells by transcriptional inhibition of PPP2CA/YAP axis (Li, Li, et al. 2023).